New cancer clinical trial: Carboplatin +/- Nivolumab in Metastatic Triple Negative Breast Cancer

Published on: January 30, 2018 at 12:00PM
Condition:   Breast Cancer
Interventions:   Drug: Carboplatin;   Drug: Nivolumab
Sponsors:   Dana-Farber Cancer Institute;   Bristol-Myers Squibb
Not yet recruiting
http://ift.tt/2nnHZye